Pfizer A0221066

Mar 3, 2021

Started: 1/2010

Study Name: An Open-Label, Dose-Escalating Study Of The Pharmacokinetics, Safety And Tolerability Of study drug In Pediatric Overactive Bladder Patients Aged 8-17 Years

Indication: UTI

Principal Investigator: Brad Brabec

This study is no longer active

Current Studies